These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 27240493

  • 21. Challenges in managing drooling in children.
    Drug Ther Bull; 2015 Jun; 53(6):66-8. PubMed ID: 26069159
    [Abstract] [Full Text] [Related]

  • 22. Effectiveness and safety of botulinum toxin in comparison with surgery for drooling in paediatric patients with neurological disorders: a systematic review.
    Silva JPS, Faria LV, Almeida RC, Medeiros YL, Guimarães LDA.
    Br J Oral Maxillofac Surg; 2022 Jun; 60(5):e691-e701. PubMed ID: 35227530
    [Abstract] [Full Text] [Related]

  • 23. Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy.
    Banerjee KJ, Glasson C, O'Flaherty SJ.
    Dev Med Child Neurol; 2006 Nov; 48(11):883-7. PubMed ID: 17044954
    [Abstract] [Full Text] [Related]

  • 24. Salivary gland botulinum toxin injections for drooling in children with cerebral palsy and neurodevelopmental disability: a systematic review.
    Rodwell K, Edwards P, Ware RS, Boyd R.
    Dev Med Child Neurol; 2012 Nov; 54(11):977-87. PubMed ID: 22946706
    [Abstract] [Full Text] [Related]

  • 25. Interdisciplinary assessment and treatment of paediatric drooling: two decades of experience by the Nijmegen saliva control team reflected in a stepwise algorithm.
    Orriëns LB, de Groot SAF, van der Burg JJW, van den Hoogen FJA, van Hulst K, Erasmus CE.
    Eur J Pediatr; 2024 Sep; 183(9):3979-3985. PubMed ID: 38943011
    [Abstract] [Full Text] [Related]

  • 26. Botulinum toxin effect on salivary flow rate in children with cerebral palsy.
    Jongerius PH, Rotteveel JJ, van Limbeek J, Gabreëls FJ, van Hulst K, van den Hoogen FJ.
    Neurology; 2004 Oct 26; 63(8):1371-5. PubMed ID: 15505151
    [Abstract] [Full Text] [Related]

  • 27. Effects of treatments for drooling on caries risk in children and adolescents with cerebral palsy.
    Gutierrez GM, Siqueira VL, Loyola-Rodriguez JP, Diniz MB, Guaré RO, Ferreira AC, Santos MT.
    Med Oral Patol Oral Cir Bucal; 2019 Mar 01; 24(2):204-210. PubMed ID: 30818313
    [Abstract] [Full Text] [Related]

  • 28. BOTOX-A injection of salivary glands for drooling.
    Alvarenga A, Campos M, Dias M, Melão L, Estevão-Costa J.
    J Pediatr Surg; 2017 Aug 01; 52(8):1283-1286. PubMed ID: 28277296
    [Abstract] [Full Text] [Related]

  • 29. [Drooling therapy in children with neurological disorders].
    Táboas-Pereira MA, Paredes-Mercado C, Alonso-Curcó X, Badosa-Pagès J, Muchart J, Póo P.
    Rev Neurol; 2015 Jul 16; 61(2):66-70. PubMed ID: 26156441
    [Abstract] [Full Text] [Related]

  • 30. US-guided botulinum toxin injection for excessive drooling in children.
    Çiftçi T, Akıncı D, Yurttutan N, Akhan O.
    Diagn Interv Radiol; 2013 Jul 16; 19(1):56-60. PubMed ID: 22798155
    [Abstract] [Full Text] [Related]

  • 31. Factors in the Efficacy, Safety, and Impact on Quality of Life for Treatment of Drooling with Botulinum Toxin Type A in Patients with Cerebral Palsy.
    Gonzalez-L MD, Martinez C, Bori Y Fortuny I, Suso-Vergara S.
    Am J Phys Med Rehabil; 2017 Feb 16; 96(2):68-76. PubMed ID: 28099276
    [Abstract] [Full Text] [Related]

  • 32. Controlling sialorrhoea: a review of available treatment options.
    Potulska A, Friedman A.
    Expert Opin Pharmacother; 2005 Aug 16; 6(9):1551-4. PubMed ID: 16086642
    [Abstract] [Full Text] [Related]

  • 33. Onabotulinumtoxin A Treatment of Drooling in Children with Cerebral Palsy: A Prospective, Longitudinal Open-Label Study.
    Møller E, Pedersen SA, Vinicoff PG, Bardow A, Lykkeaa J, Svendsen P, Bakke M.
    Toxins (Basel); 2015 Jun 30; 7(7):2481-93. PubMed ID: 26134257
    [Abstract] [Full Text] [Related]

  • 34. Submandibular duct ligation after botulinum neurotoxin A treatment of drooling in children with cerebral palsy.
    Bekkers S, Pruijn IMJ, Van Hulst K, Delsing CP, Erasmus CE, Scheffer ART, Van Den Hoogen FJA.
    Dev Med Child Neurol; 2020 Jul 30; 62(7):861-867. PubMed ID: 32149393
    [Abstract] [Full Text] [Related]

  • 35. [Drooling in neuropediatric patients].
    Steffen A, Ortfeld S, Schönweiler R.
    Klin Padiatr; 2011 Jan 30; 223(1):5-9. PubMed ID: 21271513
    [Abstract] [Full Text] [Related]

  • 36. Botulinum toxin type B for sialorrhoea in children with cerebral palsy: a randomized trial comparing three doses.
    Basciani M, Di Rienzo F, Fontana A, Copetti M, Pellegrini F, Intiso D.
    Dev Med Child Neurol; 2011 Jun 30; 53(6):559-64. PubMed ID: 21413974
    [Abstract] [Full Text] [Related]

  • 37. Repeated treatments of drooling with botulinum toxin B in neurology.
    Møller E, Daugaard D, Holm O, Winge K, Bardow A, Lykkeaa J, Belhage B, Bakke M.
    Acta Neurol Scand; 2015 Jan 30; 131(1):51-7. PubMed ID: 25270197
    [Abstract] [Full Text] [Related]

  • 38. Botulinum toxin A as a treatment for excessive drooling in children.
    Bothwell JE, Clarke K, Dooley JM, Gordon KE, Anderson R, Wood EP, Camfield CS, Camfield PR.
    Pediatr Neurol; 2002 Jul 30; 27(1):18-22. PubMed ID: 12160968
    [Abstract] [Full Text] [Related]

  • 39. Effectiveness of submandibular duct relocation in 91 children with excessive drooling: A prospective cohort study.
    Kok SE, Erasmus CE, Scheffer ART, van Hulst K, Rovers MM, van den Hoogen FJA.
    Clin Otolaryngol; 2018 Dec 30; 43(6):1471-1477. PubMed ID: 29989346
    [Abstract] [Full Text] [Related]

  • 40. Management of oral secretions in neurological disease.
    McGeachan AJ, Mcdermott CJ.
    Pract Neurol; 2017 Apr 30; 17(2):96-103. PubMed ID: 28188210
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.